Clinical Trial Update: HERPET- A Novel PET Imaging Study of HER2 in Breast Cancer [NA]

View source ↗

Summary

A clinical trial update announcing a novel PET imaging agent (HERPET) to visualize HER2 expression in breast cancer, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Imperial College London | Conditions: Breast Cancer | NA | Status: RECRUITING